Spanish doctors review rare cancer Drug's Real-World impact
NCT ID NCT06837090
Summary
This study looked back at medical records to learn how 20 Spanish cancer patients with a specific, rare genetic change (NTRK fusion) responded to the drug larotrectinib. The patients received the drug through a special access program before it was commercially available. The goal was to gather real-world information on how well the treatment worked and how long its benefits lasted for these patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID NEOPLASMS WITH NTRK FUSIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clinic de Barcelona
Barcelona, 08036, Spain
-
Hospital Clínico Santiago de Compostela
Santiago de Compostela, La Coruña, 15706, Spain
-
Hospital Quirón Salud Torrevieja
Torrevieja, Alicante, 03184, Spain
-
Hospital San Joan de Deu
Esplugues de Llobregat, Barcelona, 08950, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Infanta Sofía
San Sebastián de los Reyes, Madrid, 28702, Spain
-
Hospital Universitario Insular de Gran Canaria
Las Palmas de Gran Canaria, Las Palmas, 35016, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario Lucus Augusti
Lugo, 27003, Spain
-
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, 39008, Spain
-
Hospital Universitario Son Espases
Palma, Baleres, 07120, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital Universitario de Cruces
Barakaldo, Bizkaia, 48903, Spain
-
Hospital Universitario de Navarra
Pamplona, Navarre, 31008, Spain
Conditions
Explore the condition pages connected to this study.